Allostery Investments LP

Investment Portfolio & 13F Holdings Analysis

About

Allostery Investments LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 41 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AKRO",
  "EWTX",
  "CNTA",
  "ALKS",
  "INSM",
  "ARQT",
  "MDGL",
  "ABVX",
  "SWTX",
  "LEGN",
  "AVTX",
  "AMLX",
  "PHGE",
  "APGE",
  "TARS",
  "KALV",
  "LXEO",
  "RLYB",
  "IONS",
  "PMN",
  "ZURA",
  null,
  "PLRX",
  "SLNO",
  "ACLX",
  "ETNB",
  "GOSS",
  "WVE",
  null,
  "CNTX",
  "ELDN",
  "EOLS",
  "VRNA",
  "VIR",
  "XENE",
  "ORKA",
  "PCVX",
  "BEAM",
  "BBIO",
  "CYTK"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 41
Total Value: 69335050
Accession Number: 0001013594-25-000654
Form Type: 13F-HR
CIK: allostery-investments-lp
Manager Name: Allostery-Investments-Lp

Data Enrichment

95% identified

39 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

41 positions • $69,335.05K total value

41 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 3

Sort by:

Abivax S.A.

ABVX|00370M103

Shares:1.1M

Value:$6.9M

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:382.5K

Value:$5.5M

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:458.3K

Value:$5.3M

Merus N.V.

MRUS|N5749R100

Shares:124.7K

Value:$5.2M

Evolus, Inc.

EOLS|30052C107

Shares:412.8K

Value:$5.0M

Apogee Therapeutics, Inc.

APGE|03770N101

Shares:110.0K

Value:$4.1M

Alkermes plc.

ALKS|G01767105

Shares:115.0K

Value:$3.8M

008064107

Shares:1.4M

Value:$3.6M

Zura Bio Ltd

ZURA|G9TY5A101

Shares:2.3M

Value:$3.0M

Arcellx, Inc.

ACLX|03940C100

Shares:44.0K

Value:$2.9M

CYTOKINETICS INC

CYTK|23282W605

Shares:70.0K

Value:$2.8M

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:80.0K

Value:$2.8M

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:52.5K

Value:$2.3M

Beam Therapeutics Inc.

BEAM|07373V105

Shares:92.8K

Value:$1.8M

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:20.0K

Value:$1.4M

Vaxcyte, Inc.

PCVX|92243G108

Shares:32.0K

Value:$1.2M

IONIS PHARMACEUTICALS INC

IONS|462222100

Shares:35.0K

Value:$1.1M

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:30.0K

Value:$1.0M

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:266.1K

Value:$942.0K

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:107.1K

Value:$858.2K

Instrument	Shares		Other Manager	Value
Abivax S.A.(ABVXcusip00370M103)	1.1M	QoQ +85.98% (+508.4K) YoY-	All Managers (Combined)	$6.9M	QoQ +58.80% (+$2.5M) YoY-
Centessa Pharmaceuticals plc(CNTAcusip152309100)	382.5K	QoQ +34.44% (+98.0K) YoY-	All Managers (Combined)	$5.5M	QoQ +15.42% (+$735.0K) YoY-
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	458.3K	QoQ -4.34% (-20.8K) YoY-	All Managers (Combined)	$5.3M	QoQ +30.33% (-$1.2M) YoY-
Merus N.V.(MRUScusipN5749R100)	124.7K	QoQ +473.53% (+102.9K) YoY-	All Managers (Combined)	$5.2M	QoQ +474.07% (+$4.3M) YoY-
Evolus, Inc.(EOLScusip30052C107)	412.8K	QoQ -4.25% (-18.4K) YoY-	All Managers (Combined)	$5.0M	QoQ +4.32% (-$205.9K) YoY-
Apogee Therapeutics, Inc.(APGEcusip03770N101)	110.0K	QoQ +10.00% (-10.0K) YoY-	All Managers (Combined)	$4.1M	QoQ -9.28% (-$420.4K) YoY-
Alkermes plc.(ALKScusipG01767105)	115.0K	QoQ -4.16% (-5.0K) YoY-	All Managers (Combined)	$3.8M	QoQ +10.02% (-$346.1K) YoY-
(cusip008064107)✕	1.4M	QoQ +67.10% (+570.9K) YoY-	All Managers (Combined)	$3.6M	QoQ +58.28% (+$1.3M) YoY-
Zura Bio Ltd(ZURAcusipG9TY5A101)	2.3M	QoQ +2229.38% (+2.2M) YoY-	All Managers (Combined)	$3.0M	QoQ +1101.96% (+$2.8M) YoY-
Arcellx, Inc.(ACLXcusip03940C100)	44.0K	QoQ +25.71% (+9.0K) YoY-	All Managers (Combined)	$2.9M	QoQ +7.53% (+$202.3K) YoY-
CYTOKINETICS INC(CYTKcusip23282W605)	70.0K	QoQ +7.69% (-5.0K) YoY-	All Managers (Combined)	$2.8M	QoQ -7.98% (-$244.3K) YoY-
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	80.0K	QoQ NEW(+80.0K) YoY-	All Managers (Combined)	$2.8M	QoQ NEW(+$2.8M) YoY-
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	52.5K	QoQ NEW(+52.5K) YoY-	All Managers (Combined)	$2.3M	QoQ NEW(+$2.3M) YoY-
Beam Therapeutics Inc.(BEAMcusip07373V105)	92.8K	QoQ NEW(+92.8K) YoY-	All Managers (Combined)	$1.8M	QoQ NEW(+$1.8M) YoY-
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	20.0K	QoQ NEW(+20.0K) YoY-	All Managers (Combined)	$1.4M	QoQ NEW(+$1.4M) YoY-
Vaxcyte, Inc.(PCVXcusip92243G108)	32.0K	QoQ NEW(+32.0K) YoY-	All Managers (Combined)	$1.2M	QoQ NEW(+$1.2M) YoY-
IONIS PHARMACEUTICALS INC(IONScusip462222100)	35.0K	QoQ -46.15% (-30.0K) YoY-	All Managers (Combined)	$1.1M	QoQ -53.53% (-$1.2M) YoY-
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	30.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.0M	QoQ -14.41% (-$169.5K) YoY-
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	266.1K	QoQ NEW(+266.1K) YoY-	All Managers (Combined)	$942.0K	QoQ NEW(+$942.0K) YoY-
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	107.1K	QoQ +46.13% (+33.8K) YoY-	All Managers (Combined)	$858.2K	QoQ +57.54% (+$313.5K) YoY-